An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.

Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) are the hepatic manifestations of the metabolic syndrome; worrisome is the booming increase in pediatric age. To recreate the full spectrum of juvenile liver pathology and investigate the gender impact, male and femal...

Full description

Bibliographic Details
Main Authors: Veronica Marin, Natalia Rosso, Matteo Dal Ben, Alan Raseni, Manuela Boschelle, Cristina Degrassi, Ivana Nemeckova, Petr Nachtigal, Claudio Avellini, Claudio Tiribelli, Silvia Gazzin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4938400?pdf=render
_version_ 1811294926948794368
author Veronica Marin
Natalia Rosso
Matteo Dal Ben
Alan Raseni
Manuela Boschelle
Cristina Degrassi
Ivana Nemeckova
Petr Nachtigal
Claudio Avellini
Claudio Tiribelli
Silvia Gazzin
author_facet Veronica Marin
Natalia Rosso
Matteo Dal Ben
Alan Raseni
Manuela Boschelle
Cristina Degrassi
Ivana Nemeckova
Petr Nachtigal
Claudio Avellini
Claudio Tiribelli
Silvia Gazzin
author_sort Veronica Marin
collection DOAJ
description Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) are the hepatic manifestations of the metabolic syndrome; worrisome is the booming increase in pediatric age. To recreate the full spectrum of juvenile liver pathology and investigate the gender impact, male and female C57Bl/6 mice were fed with high fat diet plus fructose in the drinking water (HFHC) immediately after weaning (equal to 3-years old human), and disease progression followed for 16 weeks, until adults (equal to 30-years old human). 100% of subjects of both genders on HFHC diet developed steatosis in 4weeks, and some degree of fibrosis in 8weeks, with the 86% of males and 15% of females presenting a stage 2 fibrosis at 16weeks. Despite a similar final liver damage both groups, a sex difference in the pathology progression was observed. Alterations in glucose homeostasis, dyslipidemia, hepatomegaly and obese phenotype were evident from the very beginning in males with an increased hepatic inflammatory activity. Conversely, such alterations were present in females only at the end of the HFHC diet (with the exception of insulin resistance and the hepatic inflammatory state). Interestingly, only females showed an altered hepatic redox state. This juvenile model appears a good platform to unravel the underlying gender dependent mechanisms in the progression from NAFLD to NASH, and to characterize novel therapeutic approaches.
first_indexed 2024-04-13T05:25:50Z
format Article
id doaj.art-8877189aed67467aafe2678a3dc7438d
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T05:25:50Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-8877189aed67467aafe2678a3dc7438d2022-12-22T03:00:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01117e015881710.1371/journal.pone.0158817An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.Veronica MarinNatalia RossoMatteo Dal BenAlan RaseniManuela BoschelleCristina DegrassiIvana NemeckovaPetr NachtigalClaudio AvelliniClaudio TiribelliSilvia GazzinNon Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) are the hepatic manifestations of the metabolic syndrome; worrisome is the booming increase in pediatric age. To recreate the full spectrum of juvenile liver pathology and investigate the gender impact, male and female C57Bl/6 mice were fed with high fat diet plus fructose in the drinking water (HFHC) immediately after weaning (equal to 3-years old human), and disease progression followed for 16 weeks, until adults (equal to 30-years old human). 100% of subjects of both genders on HFHC diet developed steatosis in 4weeks, and some degree of fibrosis in 8weeks, with the 86% of males and 15% of females presenting a stage 2 fibrosis at 16weeks. Despite a similar final liver damage both groups, a sex difference in the pathology progression was observed. Alterations in glucose homeostasis, dyslipidemia, hepatomegaly and obese phenotype were evident from the very beginning in males with an increased hepatic inflammatory activity. Conversely, such alterations were present in females only at the end of the HFHC diet (with the exception of insulin resistance and the hepatic inflammatory state). Interestingly, only females showed an altered hepatic redox state. This juvenile model appears a good platform to unravel the underlying gender dependent mechanisms in the progression from NAFLD to NASH, and to characterize novel therapeutic approaches.http://europepmc.org/articles/PMC4938400?pdf=render
spellingShingle Veronica Marin
Natalia Rosso
Matteo Dal Ben
Alan Raseni
Manuela Boschelle
Cristina Degrassi
Ivana Nemeckova
Petr Nachtigal
Claudio Avellini
Claudio Tiribelli
Silvia Gazzin
An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.
PLoS ONE
title An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.
title_full An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.
title_fullStr An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.
title_full_unstemmed An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.
title_short An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.
title_sort animal model for the juvenile non alcoholic fatty liver disease and non alcoholic steatohepatitis
url http://europepmc.org/articles/PMC4938400?pdf=render
work_keys_str_mv AT veronicamarin ananimalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT nataliarosso ananimalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT matteodalben ananimalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT alanraseni ananimalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT manuelaboschelle ananimalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT cristinadegrassi ananimalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT ivananemeckova ananimalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT petrnachtigal ananimalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT claudioavellini ananimalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT claudiotiribelli ananimalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT silviagazzin ananimalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT veronicamarin animalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT nataliarosso animalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT matteodalben animalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT alanraseni animalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT manuelaboschelle animalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT cristinadegrassi animalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT ivananemeckova animalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT petrnachtigal animalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT claudioavellini animalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT claudiotiribelli animalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT silviagazzin animalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis